Development and Evaluation of Novel Self-Nanoemulsifying Drug Delivery Systems Based on a Homolipid from <i>Capra hircus</i> and Its Admixtures with Melon Oil for the Delivery of Indomethacin

<table>Inhibition of egg albumin-induced inflammaution by indomethacin contained in self-emulsifying drug delivery systems. Note that 2A contains indomethacin in SNEDDS formulated from goat fat with surfactant blend (1 : 1 of Tween 60 and Tween 80) and cosurfactant (Span 85) in the ratio of 35 : 45 : 20, respectively; 4C contains indomethacin in SNEDDS formulated from goat fat and melon oil blend (1 : 1) combined with surfactant blend (1 : 1 of Tween 60 and Tween 80) and cosurfactant (Span 85) in the ratio of 25 : 60 : 15, respectively.</table>

Journal of Pharmaceutics

fig4

Figure 4

Figure 4: Development and Evaluation of Novel Self-Nanoemulsifying Drug Delivery Systems Based on a Homolipid from <i>Capra hircus</i> and Its Admixtures with Melon Oil for the Delivery of Indomethacin 

Figure 4 | Development and Evaluation of Novel Self-Nanoemulsifying Drug Delivery Systems Based on a Homolipid from Capra hircus and Its Admixtures with Melon Oil for the Delivery of Indomethacin 